Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 2 to 16

PENG plus lateral femoral cutaneous nerve block versus lumbar and sacral erector spinae plane blocks for pediatric hip surgery

Official title: Comparison of Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block With Lateral Femoral Cutaneous Nerve Block (LFCB) Versus Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB and S-ESPB) in Pediatric Hip Surgery: A Randomized Controlled Trial

Run by Poznan University of Medical Sciences · NCT07023094 · Data updated 2026-11-12

This trial will test whether combining a PENG block with a lateral femoral cutaneous nerve block gives better pain relief and lowers opioid use than lumbar and sacral erector spinae plane blocks in children aged 2–16 having elective hip surgery.

More Hip Arthropathy trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages2 Years to 16 Years
SexAll
Enrollment60 (estimated)
SponsorPoznan University of Medical Sciences
Academic / other
Locations1 site (Poznan)
StatusRecruiting
StartedJune 16, 2025
Main results expectedJanuary 30, 2027
Study endsJanuary 30, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07023094 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2–16 scheduled for elective orthopedic hip surgery (such as osteotomies, reconstructions, or arthroscopy) with ASA physical status I–III and written guardian consent are the intended participants.

Probably not a fit

Patients with infection at intended injection sites, coagulopathy or anticoagulant use, known allergy to study drugs, significant neurological or cognitive impairment, chronic opioid use, or other severe systemic disease are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial enrolls children aged 2–16 undergoing elective orthopedic hip procedures to compare two regional anesthesia strategies: a pericapsular nerve group (PENG) block combined with a lateral femoral cutaneous nerve block versus lumbar and sacral erector spinae plane blocks. All blocks use 0.2% ropivacaine, and the protocol will examine whether adding dexamethasone or dexmedetomidine as adjuvants prolongs analgesia. Primary outcomes include postoperative pain scores and opioid consumption, with secondary measures of block-related complications and recovery milestones. The trial seeks to identify which technique provides superior analgesia and fewer opioid-related side effects in the pediatric hip surgery population.

Why it matters

Potential benefit: If successful, the preferred block technique could reduce postoperative pain and opioid requirements and speed recovery after pediatric hip surgery.

How similar studies have gone: Early adult studies and limited pediatric reports suggest PENG and erector spinae plane blocks can provide effective hip analgesia, but direct randomized comparisons in children are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric patients aged between 2 and 16 years.
* Scheduled for elective orthopedic hip surgery, including: Osteotomies and Hip reconstruction surgeries
* ASA (American Society of Anesthesiologists) physical status classification: I-III.
* Written informed consent obtained from the patient's legal guardian(s).

Exclusion Criteria:

* Known allergy or hypersensitivity to any of the study medications
* Presence of infection or inflammation at the intended injection site(s) of regional anesthesia.
* Coagulopathy or bleeding disorders (including patients on anticoagulant therapy) that contraindicate nerve blocks.
* Neurological disorders or peripheral neuropathies that could influence sensory or motor assessment of the lower limbs.
* Cognitive impairment or behavioral disorders significantly affecting pain assessment accuracy or cooperation.
* History of chronic opioid use or known substance abuse.
* Severe systemic disease or condition compromising patient safety or interfering with study protocol adherence.

Where it's running

  • Poznan University of Medical Sciences
    Poznan, Poland
    Recruiting

Study contacts

  • Principal investigator: Malgorzata Reysner, M.D. Ph.D. — Poznan University of Medical Sciences
  • Study coordinator: Malgorzata Reysner
  • Email: mreysner@ump.edu.pl
  • Phone: +48 61 873 83 03

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.